RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 25, 2024 -- Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the annual meeting of the Radiological Society of North America, held from Dec. 1 to 5 in Chicago.
Elena Ghotbi, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined whether LT4 use and higher thyroid hormone levels within the reference range are associated with greater bone loss over time in older adults. The analysis included data from participants (aged 65 years and older) in the Baltimore Longitudinal Study of Aging (81 LT4 users and 364 propensity-matched nonusers).
The researchers found that during a median follow-up of 6.3 years, LT4 use was associated with greater longitudinal loss of total body bone mass (beta, −6.53) and total body bone density (beta, −0.0014). With an increasing tertile of average free thyroxine, the association was stronger.
"Longitudinal loss of bone mass and density was greater among euthyroid LT4 users," the authors write. "The more pronounced effects at higher levels of free thyroxine suggest that LT4 use may be associated with a relative excess of thyroid hormone in some older adults on therapy, even with thyroid-stimulating hormone levels within the reference range."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Opportunistic CT Bone Density Screening Improves Osteoporosis Screening Rate
MONDAY, March 10, 2025 -- Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in...
Offspring of Women With Epilepsy Experience Decreased Bone Metabolism
FRIDAY, Feb. 14, 2025 -- Women with epilepsy may have offspring with decreased bone metabolism and lower birth weight, according to a study published online Feb. 3 in the Annals...
Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar Disorder
WEDNESDAY, Feb. 12, 2025 -- Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.